Hainan Haiyao Co Ltd banner
H

Hainan Haiyao Co Ltd
SZSE:000566

Watchlist Manager
Hainan Haiyao Co Ltd
SZSE:000566
Watchlist
Price: 6.21 CNY -0.32% Market Closed
Market Cap: ¥8.1B

Relative Value

The Relative Value of one Hainan Haiyao Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 6.21 CNY, Hainan Haiyao Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hainan Haiyao Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Hainan Haiyao Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hainan Haiyao Co Ltd
SZSE:000566
8.1B CNY 9.8 -5.5 -10.2 -10.2
US
Eli Lilly and Co
NYSE:LLY
965.7B USD 14.8 46.8 31.5 33.6
US
Johnson & Johnson
NYSE:JNJ
594B USD 6.3 22.2 15.4 18.9
CH
Roche Holding AG
SIX:ROG
291.5B CHF 4.8 31 13.1 15.3
UK
AstraZeneca PLC
LSE:AZN
236.4B GBP 5.5 31.6 17.4 24.5
CH
Novartis AG
SIX:NOVN
242.5B CHF 5.5 22.3 13.8 17.7
US
Merck & Co Inc
NYSE:MRK
303.7B USD 4.7 16.6 10.4 12.2
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.7 11.4
US
Pfizer Inc
NYSE:PFE
152.2B USD 2.4 19.6 7.3 9.8
UK
GSK plc
XETRA:GS71
105.9B EUR 2.8 16.1 8.1 11.5
P/E Multiple
Earnings Growth PEG
CN
H
Hainan Haiyao Co Ltd
SZSE:000566
Average P/E: 24.4
Negative Multiple: -5.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.8
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22.2
7%
3.2
CH
Roche Holding AG
SIX:ROG
31
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.6
26%
1.2
CH
Novartis AG
SIX:NOVN
22.3
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.6
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
7%
1.9
US
Pfizer Inc
NYSE:PFE
19.6
26%
0.8
UK
GSK plc
XETRA:GS71
16.1
18%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
H
Hainan Haiyao Co Ltd
SZSE:000566
Average EV/EBITDA: 46
Negative Multiple: -10.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
31.5
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.4
2%
7.7
CH
Roche Holding AG
SIX:ROG
13.1
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.4
11%
1.6
CH
Novartis AG
SIX:NOVN
13.8
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.4
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.7
7%
1.4
US
Pfizer Inc
NYSE:PFE
7.3
-4%
N/A
UK
GSK plc
XETRA:GS71
8.1
2%
4.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
H
Hainan Haiyao Co Ltd
SZSE:000566
Average EV/EBIT: 99
Negative Multiple: -10.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.6
17%
2
US
Johnson & Johnson
NYSE:JNJ
18.9
6%
3.1
CH
Roche Holding AG
SIX:ROG
15.3
6%
2.5
UK
AstraZeneca PLC
LSE:AZN
24.5
24%
1
CH
Novartis AG
SIX:NOVN
17.7
12%
1.5
US
Merck & Co Inc
NYSE:MRK
12.2
6%
2
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
8%
1.4
US
Pfizer Inc
NYSE:PFE
9.8
-1%
N/A
UK
GSK plc
XETRA:GS71
11.5
12%
1